Low plasma appearance of (+)-catechin and (−)-catechin compared with epicatechin after consumption of beverages prepared from nonalkalized or alkalized cocoa—A randomized, double-blind trial

12Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

Abstract

Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (−)-epicatechin, and procyanidins and more (−)-catechin than nonalkalized cocoa powder (NALC). This may affect the plasma appearance of monomeric flavan-3-ol stereoisomers after consumption of NALC vs. ALC. Within a randomized, crossover trial, 12 healthy nonsmokers ingested a milk-based cocoa beverage providing either NALC or ALC. Blood was collected before and within 6 h postconsumption. (+)-Catechin, (−)-catechin, and epicatechin were analyzed in plasma by HPLC as sum of free and glucuronidated metabolites. Pharmacokinetic parameters were obtained by a one-compartment model with nonlinear regression methods. For epicatechin in plasma, total area under the curve within 6 h postconsumption (AUC0–6h) and incremental AUC0–6h were additionally calculated by using the linear trapezoidal method. After consumption of NALC and ALC, (+)-catechin and (−)-catechin were mostly not detectable in plasma, in contrast to epicatechin. For epicatechin, total AUC0–6h was different between both treatments, but not incremental AUC0–6h. Most kinetic parameters were similar for both treatments, but they varied strongly between individuals. Thus, epicatechin is the main monomeric flavan-3-ol in plasma after cocoa consumption. Whether NALC should be preferred against ALC due to its higher (−)-epicatechin content remains unclear with regard to the results on incremental AUC0–6h. Future studies should investigate epicatechin metabolites in plasma for a period up to 24 h in a larger sample size, taking into account genetic polymorphisms in epicatechin metabolism and should consider all metabolites to understand inter-individual differences after cocoa intake.

References Powered by Scopus

Meta-analysis in clinical trials

32715Citations
N/AReaders
Get full text

Nonparametric estimates of standard error: The jackknife, the bootstrap and other methods

1058Citations
N/AReaders
Get full text

Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials

986Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Technological and Biotechnological Processes To Enhance the Bioavailability of Dietary (Poly)phenols in Humans

55Citations
N/AReaders
Get full text

Reactivity of flavanols: Their fate in physical food processing and recent advances in their analysis by depolymerization

40Citations
N/AReaders
Get full text

PXR is a target of (-)-epicatechin in skeletal muscle

13Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ellinger, S., Reusch, A., Henckes, L., Ritter, C., Zimmermann, B. F., Ellinger, J., … Helfrich, H. P. (2020). Low plasma appearance of (+)-catechin and (−)-catechin compared with epicatechin after consumption of beverages prepared from nonalkalized or alkalized cocoa—A randomized, double-blind trial. Nutrients, 12(1). https://doi.org/10.3390/nu12010231

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

66%

Researcher 5

17%

Lecturer / Post doc 3

10%

Professor / Associate Prof. 2

7%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 11

55%

Pharmacology, Toxicology and Pharmaceut... 3

15%

Engineering 3

15%

Medicine and Dentistry 3

15%

Save time finding and organizing research with Mendeley

Sign up for free